Full-Time

Senior Director of Healthcare Compliance

Updated on 9/4/2026

Progyny

Progyny

501-1,000 employees

Fertility benefits management for employers

Compensation Overview

$160k - $175k/yr

+ Bonus + Equity

No H1B Sponsorship

New York, NY, USA

Hybrid

Three days on-site per week, Tuesday through Thursday, are required.

Bachelor's, MBA, JD

Category
Risk & Compliance (1)

Get referred to Progyny

See people who can refer or advise you

Requirements
  • A minimum of 8-10 years of experience in compliance or regulatory affairs within the insurance or healthcare industries, with expertise in state-specific regulations.
  • Strong understanding of licensing processes and regulatory requirements for health insurance providers and/or pharmacy benefit managers.
  • A proven track record of building and managing relationships with regulatory agencies and navigating complex regulatory environments.
  • Experience managing and mentoring teams, with strong leadership and decision-making skills.
  • Exceptional organizational, analytical, and problem-solving abilities, with a detail-oriented approach to compliance management.
  • Excellent verbal and written communication skills, with the ability to convey complex regulatory concepts clearly to diverse stakeholders.
  • A bachelor's degree in Business Administration, Healthcare Administration, or a related field.
  • Candidates must be available to work onsite Tuesday through Thursday each week.
  • Candidates must be authorized to work in the United States without the need for sponsorship, now or in the future.
Responsibilities
  • Work with the Group Vice President, Regulatory Compliance, and compliance team members to develop, implement, and oversee the healthcare compliance program to ensure adherence to state and federal regulations and state licensing requirements.
  • Manage and maintain all healthcare-related licenses, including UM/UR, TPA, PBM, and fully insured licenses, ensuring timely renewals and compliance with associated reporting requirements in each applicable state.
  • Provide strategic guidance to leadership on evolving regulatory changes and their impact and required actions.
  • Build and maintain strong relationships with regulators, acting as the primary point of contact for compliance-related matters.
  • Lead company responses to regulatory audits, data requests, and market conduct exams, ensuring timely preparation and resolution of findings.
  • Collaborate with legal, operations, network, and product teams to ensure alignment with compliance requirements and corporate goals.
  • Provide leadership and mentorship to direct reports, fostering professional growth and ensuring the team's effectiveness.
  • Create and maintain policies, procedures, and training programs to ensure company-wide compliance awareness.
  • Partner with leadership to establish proactive strategies for managing compliance needs and driving operational excellence.
Desired Qualifications
  • An advanced degree such as a Juris Doctor, Master of Business Administration, or Master of Public Health is preferred.

Progyny is a fertility benefits manager that partners with employers to offer comprehensive fertility and family-building services to employees. It provides a wide range of services including IUI, IVF, fertility preservation, adoption assistance, and surrogacy support, all integrated into employers’ existing benefits packages. The company makes money by signing contracts with employers, typically using a fixed-fee or per-employee-per-month pricing model, and it works to deliver better clinical outcomes to reduce overall treatment costs. Unlike broader health insurers, Progyny focuses specifically on fertility care and family-building, emphasizing measurable clinical results and seamless workflow within the benefits ecosystem. Its goal is to expand access to inclusive fertility benefits while improving outcomes and controlling costs for employers and employees.

Company Size

501-1,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

2008

Get referred to Progyny

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $350.5 million, with gross margin expanding to 25.5%.
  • Progyny repurchased 10.8 million shares since November 2025, supporting per-share economics.
  • Provider-search recognition for FertilityEquity strengthens network quality and member trust into 2027.

What critics are saying

  • Q2 2026 growth still lapped a $48.5 million transition client wind-down.
  • August 2026 guidance disappointed investors; shares fell after lower third-quarter expectations.
  • Carrot Fertility and Maven Clinic pressure pricing; employers can bundle fertility elsewhere by 2027.

What makes Progyny unique

  • Progyny owns employer fertility navigation, specialty networks, and care advocates.
  • FertilityEquity and provider search make culturally responsive care visible to members.
  • Progyny Select extends coverage to smaller employers through brokers for 2027 plan years.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Family Planning Benefits

Fertility Treatment Support

Wellness Program

Mental Health Support

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Progyny
Sep 4th, 2026
How culturally responsive care is helping reduce disparities in fertility treatment.

How culturally responsive care is helping reduce disparities in fertility treatment. Fertility care is deeply personal. Every patient brings unique experiences, values, and cultural perspectives to their care. Yet many patients from historically marginalized communities report feeling unwelcome or misunderstood in healthcare environments where their lived experiences were not reflected in the care they received. While many factors contribute to these experiences, one is the longstanding lack of diversity within the healthcare workforce. Although women make up about half of the U.S. population and Black Americans nearly 14%, physicians remain disproportionately white and male-only 39% of practicing physicians are female, and just about 5% are Black. For many people seeking fertility treatment, having the option to receive care from a provider who understands their background and respects their values, preferences and lived experiences can help foster trust, communication, and engagement during treatment. Choice in care matters. In response, Janet Choi, MD, Progyny Chief Medical Officer, and other network physicians collaborated with Morehouse School of Medicine, Ferring Pharmaceuticals, and EngagedMD to develop educational content focused on advancing culturally responsive fertility care. The FertilityEquity(TM) training program is comprised of 26 evidence-based learning modules combining educational content, practical guidance, and real patient stories illustrating care gaps. The curriculum explores disparities in fertility care and delivers actionable strategies to support more equitable patient experiences and outcomes. Providers and clinics completing the coursework are recognized in the Progyny Provider Search Tool, enabling members to identify practices that have demonstrated a commitment to culturally responsive care. "Members can now more easily identify providers who have invested in culturally responsive fertility care, which is essential to improving both trust and outcomes. For many patients-particularly women of color-experiences of feeling dismissed or not fully heard remain far too common, and that can delay engagement with care at critical moments," explains Dr. Choi. The need for this type of support is reflected in persistent disparities in fertility care. Research shows that while Black women experience infertility at disproportionately higher rates, they often seek fertility care later and face greater barriers to accessing treatment. Black women may spend more than 1.5 additional years trying to conceive before seeking fertility support and are significantly more likely to report difficulty finding a preferred provider. Additionally, Black and Hispanic women are up to six times more likely to have difficulty finding a physician with whom they feel comfortable. By helping members identify providers who have completed culturally responsive care training, Progyny aims to make it easier for individuals to find care that aligns with their needs and fosters trust throughout the fertility journey. "Age is a significant factor that influences the success of fertility interventions and pregnancy outcomes. It is critical that disparities-and resultant barriers-don't contribute to delays in seeking care, particularly for historically underserved populations," says Gloria Richard-Davis, MD, MBA, Regional Dean of the Morehouse School of Medicine and Progyny Medical Advisory Board member. "With the opportunity to identify aligned providers, members can seek fertility care earlier and with greater confidence." Strong provider-patient relationships are foundational to high-quality fertility care. When patients feel heard, respected, and understood, they are more likely to engage in their care, make informed decisions, and feel empowered throughout their fertility journey. The response to the coursework has been overwhelmingly positive; participants eager to pursue the recognized culturally competent care designation to better meet the needs of diverse patient populations. Progyny's partnership with Morehouse, Ferring, and EngagedMD reflects a broader effort to raise the standard of care-ensuring that more individuals can access providers who understand their needs, engage earlier in treatment, and ultimately achieve better outcomes. This is an important step toward a future where every patient feels seen, heard, and supported throughout their fertility journey. If you're curious to learn more or if you're a provider looking to take the course, please visit FertilityEquity.

Yahoo Finance
Aug 12th, 2026
2 cash-heavy stocks to watch and 1 to avoid

Two healthcare companies with strong cash positions are attracting investor attention, whilst a fertility benefits provider faces challenges. Progyny holds $214.4 million in net cash, representing 14.2% of its market capitalisation. However, the company has struggled with underwhelming unit sales over the past two years and demonstrates below-average returns on capital. Trading at $27.95 per share, Progyny commands a 13.9x forward price-to-earnings ratio. Molina Healthcare maintains a net cash position of $1.22 billion, or 11.9% of market cap. The managed healthcare provider has achieved 13.7% annual revenue growth over five years, outpacing sector averages. Operating across 21 states, Molina serves low-income individuals through Medicaid, Medicare, and Marketplace programmes. Axos Financial, a digital banking and financial services company, holds $39.48 million in net cash, though this represents just 0.7% of its market capitalisation.

Market Wire News
Aug 7th, 2026
Progyny, Inc. to present at the Canaccord Genuity Annual Growth Conference.

Progyny, Inc. to present at the Canaccord Genuity Annual Growth Conference. August 07, 2026 10:51:30 am NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) - Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET. Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny's investor relations website at http://investors.progyny.com. About Progyny Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. Market Wire News envision a world where everyone can realize their dreams of family and ideal health. Its outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians. Its benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain's Fast 50 for NYC. For more information, visit www.progyny.com. For Further Information, Please Contact: Investors: James Hart [email protected] Media: Alexis Ford [email protected]

Yahoo Finance
Aug 7th, 2026
Progyny hits record EBITDA with revenue up 11%, repurchases $31.5M in shares

Progyny reported record quarterly revenue and adjusted EBITDA for Q2 2026. Second quarter revenue rose 5.3% year-over-year, or 11% excluding contributions from a large former client under a transition agreement in Q2 2025. The fertility benefits provider's gross margin expanded 180 basis points year-over-year, driven by efficiencies in care management and service delivery. Operating cash flow reached more than $50 million for the fourth time in five quarters. Progyny repurchased nearly 1.2 million shares for $31.5 million during the quarter under its $200 million programme. Since November, the company has bought back 10.8 million shares, reducing shares outstanding by approximately 12.5%. The company projects full-year 2026 revenue between $1.36 billion and $1.385 billion, representing growth of 5.5% to 7.5%.

Mining Press Releases
Aug 7th, 2026
Progyny, Inc. to present at the Canaccord Genuity Annual Growth Conference.

Progyny, Inc. to present at the Canaccord Genuity Annual Growth Conference. NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) - Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET. Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny's investor relations website at http://investors.progyny.com. About Progyny Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians. Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain's Fast 50 for NYC. For more information, visit www.progyny.com. For Further Information, Please Contact: Investors: James Hart [email protected] Media: Alexis Ford [email protected] Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.